Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;16(2):246-252.
doi: 10.1177/1533034616685942. Epub 2017 Jan 4.

Changes in Tumor Volumes and Spatial Locations Relative to Normal Tissues During Cervical Cancer Radiotherapy Assessed by Cone Beam Computed Tomography

Affiliations

Changes in Tumor Volumes and Spatial Locations Relative to Normal Tissues During Cervical Cancer Radiotherapy Assessed by Cone Beam Computed Tomography

Wenjuan Chen et al. Technol Cancer Res Treat. 2017 Apr.

Abstract

Purpose: To assess changes in the volumes and spatial locations of tumors and surrounding organs by cone beam computed tomography during treatment for cervical cancer.

Materials and methods: Sixteen patients with cervical cancer had intensity-modulated radiotherapy and off-line cone beam computed tomography during chemotherapy and/or radiation therapy. The gross tumor volume (GTV-T) and clinical target volumes (CTVs) were contoured on the planning computed tomography and weekly cone beam computed tomography image, and changes in volumes and spatial locations were evaluated using the volume difference method and Dice similarity coefficients.

Results: The GTV-T was 79.62 cm3 at prior treatment (0f) and then 20.86 cm3 at the end of external-beam chemoradiation. The clinical target volume changed slightly from 672.59 cm3 to 608.26 cm3, and the uterine volume (CTV-T) changed slightly from 83.72 cm3 to 80.23 cm3. There were significant differences in GTV-T and CTV-T among the different groups ( P < .001), but the clinical target volume was not significantly different in volume ( P > .05). The mean percent volume changes ranged from 23.05% to 70.85% for GTV-T, 4.71% to 6.78% for CTV-T, and 5.84% to 9.59% for clinical target volume, and the groups were significantly different ( P < .05). The Dice similarity coefficient of GTV-T decreased during the course of radiation therapy ( P < .001). In addition, there were significant differences in GTV-T among different groups ( P < .001), and changes in GTV-T correlated with the radiotherapy ( P < .001). There was a negative correlation between volume change rate (DV) and Dice similarity coefficient in the GTV-T and organs at risk ( r < 0; P < .05).

Conclusion: The volume, volume change rate, and Dice similarity coefficient of GTV-T were all correlated with increase in radiation treatment. Significant variations in tumor regression and spatial location occurred during radiotherapy for cervical cancer. Adaptive radiotherapy approaches are needed to improve the treatment accuracy for cervical cancer.

Keywords: Dice similarity coefficient; cervical cancer; cone beam computed tomography; image-guided radiation therapy; volume change rate.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Volumetric changes in GTV-T, CTV-T, and clinical target volume (CTV) during therapy.
Figure 2.
Figure 2.
The volume change rates of GTV-T, CTV-T and CTV during therapy.
Figure 3.
Figure 3.
Dice similarity coefficient (DSC) changes of GTV-T, CTV-T, clinical target volume (CTV) during therapy.

References

    1. Mell LK, Roeske JC, Mundt AJ. A survey of intensity-modulated radiation therapy use in the United States. Cancer. 2003;98(1):204–211. - PubMed
    1. Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Potter R. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008;71(4):1272–1278. - PubMed
    1. Chen MF, Tseng CJ, Tseng CC, Kuo YC, Yu CY, Chen WC. Clinical outcome in post-hysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67(5):1438–1444. - PubMed
    1. Hasselle MD, Rose B, Kochanski JD, et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011;80(5):1436–1445. - PubMed
    1. Albuquerque K, Giangreco D, Morrison C, et al. Radiation-related predictors of hematologic toxicity after concurrent chemo-radiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Int J Radiat Oncol Biol Phys. 2011;79(4):1043–1047. - PubMed

Publication types